Preoperative adjuvant therapy for locally advanced and recurrent/metastatic gastrointestinal stromal tumors: a retrospective study
Abstract Background Preoperative imatinib mesylate therapy for gastrointestinal stromal tumors (GISTs) is controversial. This study aimed to explore the clinical efficacy and optimal duration of preoperative imatinib mesylate (IM) therapy in patients with locally advanced and recurrent/metastatic GI...
Main Authors: | Jing Qi, He-Li Liu, Feng Ren, Sheng Liu, Wei Shi, Wei-Hang Liu, Gao-Qiang Cai, Guo-Qing Liao |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-04-01
|
Series: | World Journal of Surgical Oncology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12957-020-01840-9 |
Similar Items
-
Preoperative imatinib for patients with primary unresectable or metastatic/recurrent gastrointestinal stromal tumor
by: Chaoyong Shen, et al.
Published: (2014-11-01) -
Postoperative Cure for Metastatic Gastrointestinal Stromal Tumor
by: Eun Hyea Park, et al.
Published: (2018-12-01) -
Gastric Gastrointestinal Stromal Tumor with Repeated Recurrence at the Anastomosis Site in a Very Elderly Patient
by: Hye-Jin Kim, et al.
Published: (2020-10-01) -
Successful Endoscopic Resection of a Rectal Gastrointestinal Stromal Tumor Larger Than 5 cm
by: Seong Jung Kim, et al.
Published: (2021-10-01) -
An audit of gastrointestinal stromal tumors from a tertiary medical college hospital in Eastern India
by: Samrat Dutta, et al.
Published: (2018-01-01)